# LAA Clipping Versus NOACs to Prevent Stroke in Non-paroxysmal Atrial Fibrillation.

> **NCT06021808** · NA · RECRUITING · sponsor: **China National Center for Cardiovascular Diseases** · enrollment: 290 (estimated)

## Conditions studied

- Non-paroxysmal Atrial Fibrillation

## Interventions

- **PROCEDURE:** Thoracoscopic LAA clipping
- **DRUG:** Novel oral anticoagulant

## Key facts

- **NCT ID:** NCT06021808
- **Lead sponsor:** China National Center for Cardiovascular Diseases
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-04-02
- **Primary completion:** 2028-04
- **Final completion:** 2028-05
- **Target enrollment:** 290 (ESTIMATED)
- **Last updated:** 2024-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06021808

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06021808, "LAA Clipping Versus NOACs to Prevent Stroke in Non-paroxysmal Atrial Fibrillation.". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06021808. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*